News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Outpace Bio expands cell therapy R&D, nets research collaborations in Seattle
Seattle-based biotech Outpace Bio opened a new 23,000-square-foot facility as the company has new research and development efforts underway and has grown to 53 employees.
Cancer-fighting biotech startup Indapta lands $30M with assist from FDA
Seattle-area company Indapta Therapeutics has triggered round two of the $60 million Series A round raised in January 2022. The company received Food and Drug
A-Alpha Bio lands $2.4M from DOD for antibody discovery project
Seattle-based biotech A-Alpha Bio has received $2.4 million from the Department of Defense (DOD) in a joint project with Lawrence Livermore National Laboratory (LLNL). A-Alpha
Seattle startup raises $2M to make healthcare pricing data more transparent
Seattle-based startup Cascade Health raised $2 million in a pre-seed funding round to help boost its AI-powered software. The company’s software aims to increase healthcare
A day in the life as a Seagen manufacturing purification manager
For Megan Long, details matter. The details are paramount when she is establishing a safe environment to manufacture oncology medicines in a job where the
Swedish drugmaker SOBI to acquire Seattle biotech company CTI BioPharma for $1.7B
Swedish biotech giant Sobi plans to acquire Seattle-based biotech CTI BioPharma in a $1.7 billion deal. The all-cash deal is expected to close in the
Why Seattle has become a hotbed for life sciences
Seattle is a thriving hub for biotech and pharmaceutical companies, attracting top talent in the industry to the region. The agglomeration of the region’s life
Life sciences investors share tips on raising funds and conserving cash in a tight market
At the annual Life Science Innovation Northwest conference, life science funding and investment experts joined to discuss the current funding landscape in the “Finance: Defining
Lab software company Genemod raises $4.5M seed round
Genemod, a Seattle-based lab software startup, raised $4.5 million in a seed funding round. The company’s cloud-based platform helps life sciences companies and researchers manage
Evergreen Bioscience envisions new bioscience building, sets sights on larger goals
The Evergreen Bioscience Innovation Cluster is taking the first steps to develop a new facility costing up to $50 million and providing space for up
Report: Life Science Washington outlines sector’s growth during pandemic
In 2021 Washington’s life science industry employed 43,546 workers and had an economic impact of $35.5 billion, according to the latest Economic Impact Report from
Report details economic impact of Washington life science industry
The latest Economic Impact Report by the trade association Life Science Washington shows that the Washington life science industry supports more than 100,000 jobs statewide